HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Canvaxin

a polyvalent vaccine immunotherapy for melanoma of three viable irradiated melanoma cell lines which contain at least 11 known tumor-associated antigens such as MAGE-1, MAGE-3, tyrosinase, gp100, gp75, and Mart-1/Melan-A; increased IgM response in patients receiving vaccine therapy for stage II melanoma was associated with decreased recurrence and improved survival
Networked: 13 relevant articles (2 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Morton, Donald L: 10 articles (02/2012 - 08/2002)
2. Essner, Richard: 5 articles (11/2007 - 08/2002)
3. Hsueh, Eddy C: 4 articles (10/2004 - 10/2002)
4. Hoon, Dave S B: 3 articles (02/2012 - 10/2002)
5. Ye, Xing: 3 articles (11/2007 - 12/2002)
6. Gupta, Rishab K: 3 articles (01/2003 - 08/2002)
7. Foshag, Leland J: 3 articles (12/2002 - 08/2002)
8. O'Day, Steven J: 3 articles (12/2002 - 08/2002)
9. Wang, He-Jing: 2 articles (02/2012 - 10/2002)
10. Faries, Mark B: 2 articles (02/2012 - 01/2005)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Neoplasms (Cancer)
3. Colonic Neoplasms (Colon Cancer)
4. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. polyvalent melanoma cell vaccine
2. Antigens
3. Glycoproteins (Glycoprotein)
4. Antibodies
5. Sodium
6. Immunoglobulin M (IgM)
7. Carbon Monoxide
8. Neoplasm Antigens (Tumor Antigens)
9. aprinocarsen

Related Therapies and Procedures

1. Immunotherapy